Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Stephen Daw
Observed names:
Daw, S,
Daw, Stephen,
S Daw,
S. Daw
Observed institutions:
University College Hospital,
University College London Hospitals NHS Foundation Trust,
Great Ormond Street Hospital,
University College Hospital, Ibadan,
North Middlesex Hospital,
University College London
show all 6
ORCID:
0000-0001-7101-5486
Observed ORCID:
0000-0001-7101-5486
OpenAlex ID:
A5087994445
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
2021
·
Christine Mauz-Körholz
, Judith Landman-Parker
, et al.
·
The Lancet Oncology
·
137
PDF
Pediatric and Adolescent Lymphoma:Comparison of Whole-Body STIR Half-Fourier RARE MR Imaging with an Enhanced PET/CT Reference for Initial Staging
2010
·
Shonit Punwani
, Stuart A. Taylor
, et al.
·
Radiology
·
130
Brentuximab vedotin for paediatric relapsed or refractory Hodgkin's lymphoma and anaplastic large-cell lymphoma: a multicentre, open-label, phase 1/2 study
2018
·
Franco Locatelli
, Christine Mauz-Koerholz
, et al.
·
The Lancet Haematology
·
103
Diffusion-weighted MRI of lymphoma: prognostic utility and implications for PET/MRI?
2012
·
Shonit Punwani
, Stuart A. Taylor
, et al.
·
European Journal of Nuclear Medicine and Molecular Imaging
·
83
Treatment of severe complicated Kawasaki disease with oral prednisolone and aspirin
2000
·
Russell C. Dale
, Moin A Saleem
, et al.
·
The Journal of Pediatrics
·
82
Treatment outcome after low intensity chemotherapy [CVP] in children and adolescents with early stage nodular lymphocyte predominant Hodgkin’s lymphoma – An Anglo-French collaborative report
2011
·
Ananth Shankar
, Georgina W. Hall
, et al.
·
European Journal of Cancer
·
72
Risk and Response Adapted Treatment Guidelines for Managing First Relapsed and Refractory Classical Hodgkin Lymphoma in Children and Young People. Recommendations from the EuroNet Pediatric Hodgkin Lymphoma Group
2020
·
Stephen Daw
, Dirk Hasenclever
, et al.
·
HemaSphere
·
71
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study
2023
·
Christine Mauz-Körholz
, Judith Landman-Parker
, et al.
·
The Lancet Oncology
·
58
PDF
Management of relapsed and refractory classical Hodgkin lymphoma in children and adolescents
2010
·
Stephen Daw
, Rob Wynn
, et al.
·
British Journal of Haematology
·
52
Nodular lymphocyte predominant H odgkin lymphoma in children and adolescents – a comprehensive review of biology, clinical course and treatment options
2012
·
Ananth Shankar
, Stephen Daw
·
British Journal of Haematology
·
46
PDF
Outcome of children with nodular lymphocyte predominant Hodgkin lymphoma – a Children's Cancer and Leukaemia Group report
2007
·
G. W. Hall
, N. Katzilakis
, et al.
·
British Journal of Haematology
·
43
PDF
Quantitative diffusion weighted MRI: A functional biomarker of nodal disease in Hodgkin lymphoma?
2011
·
Shonit Punwani
, Vineet Prakash
, et al.
·
Cancer Biomarkers
·
41
Novel markers in pediatric-type follicular lymphoma
2019
·
Claudio Agostinelli
, Ayse U Akarca
, et al.
·
Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
·
39
PDF
Whole-body MRI for staging and interim response monitoring in paediatric and adolescent Hodgkin’s lymphoma: a comparison with multi-modality reference standard including 18F-FDG-PET-CT
2018
·
Arash Latifoltojar
, Shonit Punwani
, et al.
·
European Radiology
·
39
PDF
Nivolumab, Brentuximab Vedotin, +/- Bendamustine For R/R Hodgkin Lymphoma in Children, Adolescents, and Young Adults
2022
·
Paul Harker-Murray
, Christine Mauz-Körholz
, et al.
·
Blood
·
25
18F-FDG PET/MRI for Staging and Interim Response Assessment in Pediatric and Adolescent Hodgkin Lymphoma: A Prospective Study with 18F-FDG PET/CT as the Reference Standard
2021
·
Martijn V. Verhagen
, Leon J. Menezes
, et al.
·
Journal of Nuclear Medicine
·
24
PDF
Transplant-Free Approach in Relapsed Hodgkin Lymphoma in Children, Adolescents, and Young Adults
2025
·
Stephen Daw
, Peter D. Cole
, et al.
·
JAMA Oncology
·
21
Dynamic contrast-enhanced MRI improves accuracy for detecting focal splenic involvement in children and adolescents with Hodgkin disease
2013
·
Shonit Punwani
, King Kenneth Cheung
, et al.
·
Pediatric Radiology
·
21
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma - results of the UK HD3 relapse treatment strategy
2014
·
Ananth Shankar
, Janis Hayward
, et al.
·
British Journal of Haematology
·
20
PDF
The incidence of invasive fungal infections in children, adolescents and young adults with acute lymphoblastic leukaemia/lymphoma treated with the UKALL 2011 protocol: a multicentre retrospective study
2019
·
Maeve A. O'Reilly
, Dinisha Govender
, et al.
·
British Journal of Haematology
·
17
Response-Adapted Therapy with Nivolumab and Brentuximab Vedotin (BV), Followed By BV and Bendamustine for Suboptimal Response, in Children, Adolescents, and Young Adults with Standard-Risk Relapsed/Refractory Classical Hodgkin Lymphoma
2018
·
Paul Harker-Murray
, Thierry Leblanc
, et al.
·
Blood
·
15
Response-adapted therapy (tx) with nivolumab plus brentuximab vedotin (nivo + BV) without autologous hematopoietic cell transplantation (auto-HCT) in children, adolescents, and young adults (CAYA) with low-risk relapsed/refractory (R/R) classic Hodgkin lymphoma (cHL): CheckMate 744.
2023
·
Paul David Harker-Murray
, Peter D. Cole
, et al.
·
Journal of Clinical Oncology
·
11
PDF
Phase 1/2 Study Of Brentuximab Vedotin In Pediatric Patients With Relapsed Or Refractory (R/R) Hodgkin Lymphoma (HL) Or Systemic Anaplastic Large-Cell Lymphoma (sALCL): Preliminary Phase 2 Data For Brentuximab Vedotin 1.8 Mg/Kg In The HL Study Arm
2013
·
Franco Locatelli
, Kathleen A Neville
, et al.
·
Blood
·
11
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients—Importance of multimodality imaging: Results from the EuroNet‐PHL‐C1 trial
2021
·
Lars Kurch
, Christine Mauz‐Körholz
, et al.
·
Pediatric Blood & Cancer
·
9
Nivolumab and brentuximab vedotin (BV)-based, response‐adapted treatment in children, adolescents, and young adults (CAYA) with standard-risk relapsed/refractory classical Hodgkin lymphoma (R/R cHL): Primary analysis.
2020
·
Peter D. Cole
, Christine Mauz-Körholz
, et al.
·
Journal of Clinical Oncology
·
9
Show more works
View as search
Works count:
87
Citation count:
1,279
H-index:
19
I10-index:
23
Year
Topic
Type
